Nebivolol(CAS: 99200-09-6)

Nebivolol (CAS: 99200-09-6) is regulated under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) and is classified as a pharmaceutical. It is also subject to the European Union’s Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) regulation. Additionally, in the United States, it falls under the jurisdiction of the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) for safety and environmental management.

While Nebivolol is a unique compound, there are alternative beta-blockers that can be used in synthesis, such as metoprolol and acebutolol. These alternatives can serve as effective substitutes due to their similar pharmacological properties, although their specific synthesis routes may differ from those of Nebivolol.

Nebivolol has shown consistent market growth due to its advantages in treating hypertension and heart failure compared to other beta-blockers. Research trends indicate increasing interest in its cardiovascular benefits and potential as a cardioprotective agent. However, market trends are influenced by regulatory updates and clinical trial outcomes.

Waste containing Nebivolol should be collected in appropriate containers and disposed of according to local regulations. It is typically classified as hazardous waste due to its pharmaceutical nature. Incineration, professional waste disposal services, and adherence to environmental protection precautions are recommended to ensure safe and compliant disposal. Always consult the Material Safety Data Sheet (MSDS) for specific handling and disposal instructions.